Healthequity Stock Alpha and Beta Analysis
| HQY Stock | USD 77.11 2.75 3.70% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as HealthEquity. It also helps investors analyze the systematic and unsystematic risks associated with investing in HealthEquity over a specified time horizon. Remember, high HealthEquity's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to HealthEquity's market risk premium analysis include:
Beta 0.94 | Alpha (0.42) | Risk 2.33 | Sharpe Ratio (0.18) | Expected Return (0.42) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
HealthEquity | Build AI portfolio with HealthEquity Stock |
HealthEquity Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. HealthEquity market risk premium is the additional return an investor will receive from holding HealthEquity long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in HealthEquity. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate HealthEquity's performance over market.| α | -0.42 | β | 0.94 |
HealthEquity expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of HealthEquity's Buy-and-hold return. Our buy-and-hold chart shows how HealthEquity performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.HealthEquity Market Price Analysis
Market price analysis indicators help investors to evaluate how HealthEquity stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HealthEquity shares will generate the highest return on investment. By understating and applying HealthEquity stock market price indicators, traders can identify HealthEquity position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Tanh Of Price Series | ||
| Price Floor Movement | ||
| Plus Directional Indicator | ||
| Rate of change | ||
| All Moving Average | ||
| Triple Exponential Moving Average T3 | ||
| Stick Sandwich | ||
| Mat Hold |
HealthEquity Return and Market Media
The median price of HealthEquity for the period between Thu, Nov 20, 2025 and Wed, Feb 18, 2026 is 93.26 with a coefficient of variation of 9.51. The daily time series for the period is distributed with a sample standard deviation of 8.68, arithmetic mean of 91.24, and mean deviation of 7.39. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | HealthEquity Reports Third Quarter Ended October31, 2025 Financial Results | 12/03/2025 |
2 | HealthEquity Moves to Buy Rationale Behind the Upgrade | 12/10/2025 |
3 | Disposition of 43 shares by Wellborn Gayle Furgurson of HealthEquity at 50.41 subject to Rule 16b-3 | 12/12/2025 |
4 | Tectonic Advisors LLC Grows Stake in HealthEquity, Inc. HQY | 01/02/2026 |
5 | 310 million raise positions Germanys Parloa far ahead recent European enterprise AI agent rounds | 01/15/2026 |
6 | A Look At HealthEquity Valuation After Updated 2027 Revenue Guidance | 01/21/2026 |
7 | Obsidian Security Announces End-to-End SaaS Supply Chain Protection as Agentic AI Adoption Accelerates | 01/22/2026 |
8 | Apples stock rises as Tim Cook gives just enough detail on Wall Streets most burning question - MarketWatch | 01/29/2026 |
9 | Acquisition by Natarajan Rajesh of 976 shares of HealthEquity subject to Rule 16b-3 | 02/02/2026 |
10 | Ranger Investment Management L.P. Sells 8,350 Shares of HealthEquity, Inc. HQY | 02/06/2026 |
11 | Healthequity stock hits 52-week low at 74.04 USD By Investing.com - Investing.com Nigeria | 02/12/2026 |
12 | HealthEquity Given New 110.00 Price Target at BTIG Research | 02/17/2026 |
13 | HealthEquity Updates FY 2026 Earnings Guidance | 02/18/2026 |
About HealthEquity Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including HealthEquity or other stocks. Alpha measures the amount that position in HealthEquity has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Dividend Yield | 0.07 | 0.0735 | Price To Sales Ratio | 7.2 | 6.55 |
HealthEquity Upcoming Company Events
As portrayed in its financial statements, the presentation of HealthEquity's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, HealthEquity's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of HealthEquity's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of HealthEquity. Please utilize our Beneish M Score to check the likelihood of HealthEquity's management manipulating its earnings.
| 19th of March 2024 Upcoming Quarterly Report | View | |
| 3rd of June 2024 Next Financial Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View | |
| 19th of March 2024 Next Fiscal Year End | View | |
| 31st of October 2023 Last Quarter Report | View | |
| 31st of January 2023 Last Financial Announcement | View |
Build Portfolio with HealthEquity
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.